Cart
sales@molnova.com
SM27
CAS No. 6266-54-2
SM27( —— )
Catalog No. M34029 CAS No. 6266-54-2
SM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSM27
-
NoteResearch use only, not for human use.
-
Brief DescriptionSM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.
-
DescriptionSM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFGFR
-
RecptorFGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6266-54-2
-
Formula Weight504.49
-
Molecular FormulaC21H16N2O9S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C=CC2=CC(=CC(O)=C2C1)S(=O)(=O)O)NC=3C=CC4=CC(=CC(O)=C4C3)S(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Aprutumab
Aprutumab (BAY 1179470) is a human FGFR2 monoclonal antibody with affinity to FGFR2 isoforms FGFR2-IIIB and FGFR2-IIIC. Aprutumab is commonly used to synthesize antibody-drug conjugates.
-
Lucitanib
Lucitanib is a novel VEGFR and FGFR inhibitor.
-
GSK2830371
GSK2830371 is an orally active, allosteric Wip1 phosphatase inhibitor with IC50 of 6 nM.
